Combination immunotherapy with anti-CTLA-4 and interleukin-2 redirects regulatory T cells into tumor-draining lymph nodes and expands anti-tumor CD8+ T cells in the tumor microenvironment. (6th November 2014) - Broucek, Joseph; Hughes, Tasha; Huelsmann, Erica; Lusciks, Eugene; Hill, Graham; Zayas, Janet; Poshepny, Joseph; Ruby, Carl; Kohlhapp, Frederick; Zloza, Andrew; Kaufman, Howard